Can a blood test predict catatonia treatment success?
NCT ID NCT04530734
First seen Jan 05, 2026 · Last updated May 11, 2026 · Updated 17 times
Summary
This study looks at why some people with catatonia do not respond to the standard drug lorazepam. Researchers will measure drug levels in the blood after 72 hours and check for genetic differences that affect how the drug is broken down. The goal is to find early clues to identify non-responders so treatment can be adjusted sooner. About 100 adults with catatonia will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATATONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Fontan, CHU lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.